1. A case of dermatomyositis complicated by thrombotic thrombocytopenic purpura.
- Author
-
Miyaoka Y, Urano Y, Nameda Y, Shigekiyo T, Horie T, Sano N, and Arase S
- Subjects
- Anti-Inflammatory Agents therapeutic use, Dipyridamole therapeutic use, Dyspnea etiology, Epoprostenol analogs & derivatives, Epoprostenol therapeutic use, Fatal Outcome, Fever etiology, Humans, Hypertension etiology, Immunization, Passive, Male, Methylprednisolone therapeutic use, Middle Aged, Plasma Exchange, Platelet Aggregation Inhibitors therapeutic use, Purpura, Thrombotic Thrombocytopenic drug therapy, Purpura, Thrombotic Thrombocytopenic therapy, Seizures etiology, Ticlopidine therapeutic use, Treatment Outcome, gamma-Globulins, Dermatomyositis complications, Purpura, Thrombotic Thrombocytopenic etiology
- Abstract
A 60-year-old man with dermatomyositis was admitted to our hospital because of dyspnea and hypertension. He had high fever and convulsive seizures after admission. Laboratory examinations showed hemolytic anemia, thrombocytopenia, and renal failure. A clinical diagnosis of thrombotic thrombocytopenic purpura (TTP) was made. He failed to respond to plasma exchange therapy, pulse therapy with methylprednisolone, high-dose gamma-globulin therapy, and antiplatelet therapies with ticlopidine, dipyridamole and a prostacyclin analog of beraprost sodium. He died on his 17th day in hospital. Autopsy examination revealed widespread microthrombi in his kidneys, lungs, spleen, and intestine. Only seven cases of dermatomyositis or polymyositis complicated by TTP have been cited in the literature. TTP was fatal in 6 of these 7 cases. Early diagnosis and prompt treatment may improve the outcome of TTP patients with dermatomyositis. Dermatologists should keep in mind that TTP occasionally arises as a serious complication of dermatomyositis.
- Published
- 1997
- Full Text
- View/download PDF